Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Richard W. Jenny"'
Autor:
Amelie Tedesco, Eduard Rogatsky, Colleen M. O’Hehir, James D. Daly, Richard W. Jenny, Kenneth M. Aldous
Publikováno v:
Journal of Chromatography B. :24-29
A simple method for determination of perfluorooctanoic acid (PFOA) from human serum by liquid chromatography/tandem mass spectrometry (LC/MS/MS) and utilizing high-throughput sample preparation was developed by New York State Public Health Emergency
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3feff98d5b89b1e1427b6d643be5879a
https://doi.org/10.1016/j.jchromb.2017.02.020
https://doi.org/10.1016/j.jchromb.2017.02.020
Autor:
Robin DiFrancesco, Susan L. Rosenkranz, Suzanne M. Siminski, Charlene R Taylor, Gene D. Morse, Richard W. Jenny, Poonam Pande
Publikováno v:
Therapeutic Drug Monitoring. 35:631-642
Among National Institutes of Health HIV Research Networks conducting multicenter trials, samples from protocols that span several years are analyzed at multiple clinical pharmacology laboratories (CPLs) for multiple antiretrovirals. Drug assay data a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::354ff03757187097d7536ef7a619e1e5
https://doi.org/10.1097/ftd.0b013e31828f5088
https://doi.org/10.1097/ftd.0b013e31828f5088
Autor:
Gene D. Morse, Kelly M. Tooley, Poonam Pande, Charlene R Taylor, Richard W. Jenny, Susan L. Rosenkranz, Robin DiFrancesco, Suzanne M. Siminski
Publikováno v:
Bioanalysis. 6(20)
Background: Clinical trial specimens tested for antiretroviral (ARV) concentrations often require compliance with Clinical Laboratory Improvement Act and/or the Food and Drug Administration bioanalytical guidance. Experimental: The Clinical Pharmacol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96cf6715cbbb7f1a41e0aa89f91f4a1b
https://pubmed.ncbi.nlm.nih.gov/25413704
https://pubmed.ncbi.nlm.nih.gov/25413704
Publikováno v:
Clinical Chemistry. 46:89-99
Background: Proficiency testing (PT) provides a measure of the effectiveness of laboratory quality assurance programs. Test reports are released from processes that the laboratory judges to be in conformance with quality specifications; an evaluation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::961f2a20646097ebf019e8c19a6a1239
https://doi.org/10.1093/clinchem/46.1.89
https://doi.org/10.1093/clinchem/46.1.89
Autor:
Richard W. Jenny
Publikováno v:
Clinical Chemistry. 40:723-728
Participation in a proficiency testing (PT) program is a valuable adjunct to laboratory activities dedicated to the maintenance of reliable analytical methods. The PT program may facilitate continuous quality improvement if laboratory performance is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f379cc023cf4402ade19e898c909ea7
https://doi.org/10.1093/clinchem/40.5.723
https://doi.org/10.1093/clinchem/40.5.723
Autor:
K Y Jackson, Richard W. Jenny
Publikováno v:
Clinical Chemistry. 39:76-81
Proficiency testing (PT) is pivotal in assessing laboratory qualifications for certification and licensure. PT is expected to typify routine assay performance and determine whether the laboratory is producing clinically useful test results. Conventio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::19fc406adc346322ff2577a7ee38171b
https://doi.org/10.1093/clinchem/39.1.76
https://doi.org/10.1093/clinchem/39.1.76
Autor:
Robert Rej, Richard W. Jenny
Publikováno v:
Clinical Chemistry. 38:1210-1217
The Clinical Laboratory Improvement Act of 1967 and Amendments of 1988 (CLIA '67 and CLIA '88) were enacted to ensure that clinical laboratories within the U.S. provide a quality of service that meets clinical needs for good patient care. Approved pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f72a3e9f274870a48bd29b14adbeb622
https://doi.org/10.1093/clinchem/38.7.1210
https://doi.org/10.1093/clinchem/38.7.1210
Autor:
K Y Jackson, Richard W. Jenny
Publikováno v:
Clinical Chemistry. 38:496-500
The proposed rule for the Clinical Laboratory Improvement Amendments of 1988 (CLIA '88) describes uniform standards for the design of proficiency testing (PT) challenges and for the evaluation of laboratory performance. Successful performance on PT i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa5e51a38144706d661eac11c77e1565
https://doi.org/10.1093/clinchem/38.4.496
https://doi.org/10.1093/clinchem/38.4.496
Autor:
Richard W. Jenny
Publikováno v:
Clinical Chemistry. 37:154-158
Statistical principles for analytical goal-setting were applied to two medical applications of drug-monitoring data: (a) individualizing dosage requirements by reference to a population-based therapeutic range or to a patient-specific decision value
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9327c4d450708fa6f4a700eab0153d73
https://doi.org/10.1093/clinchem/37.2.154
https://doi.org/10.1093/clinchem/37.2.154
Autor:
Lorraine M. Clarke, George H Avery, Steven J. Steindel, Kathleen M. LaBeau, Richard W. Jenny, Jason Lee, Sharon Granade
Publikováno v:
Archives of pathologylaboratory medicine. 126(12)
Objectives.—To determine operational practices in laboratories operating under a Certificate of Wavier (waived laboratories), or equivalent, under the Clinical Laboratory Improvements Amendments (CLIA) of 1988 when performing tests designated as ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4c3f029e5d4f0b63f7d63947ef9e41b
https://pubmed.ncbi.nlm.nih.gov/12456207
https://pubmed.ncbi.nlm.nih.gov/12456207